Is atogepant approved for pediatric use?

Currently, atogepant is approved for use in adults only and has not yet received approval for pediatric use. The use of atogepant in pediatric populations is an area of ongoing research, as the safety and efficacy of the medication in children and adolescents need to be carefully evaluated. It is crucial for parents or caregivers of pediatric individuals with migraines to consult with a healthcare provider to explore appropriate treatment options tailored to the specific needs of children. Continued research and clinical trials will provide valuable insights into the potential use of atogepant in pediatric migraine management, offering hope for improved treatment options for young individuals suffering from migraines.